PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Atomic resolution of the broad-spectrum antiviral drug cascade to facilitate the design of antiviral drugs

Atomic resolution of the broad-spectrum antiviral drug cascade to facilitate the design of antiviral drugs
2024-08-27
(Press-News.org)

Atomic resolution of the broad-spectrum antiviral drug cascade to facilitate the design of antiviral drugs

 

In your coverage, please use this URL to provide access to the freely available paper in PLOS Biology:   http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3002743

Article Title: The activation cascade of the broad-spectrum antiviral bemnifosbuvir characterized at atomic resolution

Author Countries: France, United States, Germany

Funding: see manuscript

END


[Attachments] See images for this press release:
Atomic resolution of the broad-spectrum antiviral drug cascade to facilitate the design of antiviral drugs Atomic resolution of the broad-spectrum antiviral drug cascade to facilitate the design of antiviral drugs 2 Atomic resolution of the broad-spectrum antiviral drug cascade to facilitate the design of antiviral drugs 3

ELSE PRESS RELEASES FROM THIS DATE:

This new technique for studying cell receptors could have sweeping implications for drug development

This new technique for studying cell receptors could have sweeping implications for drug development
2024-08-27
One in every three FDA-approved drugs targets a single superfamily of receptors dotting the surfaces of human cells. From beta blockers to antihistamines, these essential, life-saving medications trigger winding biochemical pathways, via these receptors, to ultimately prevent a heart attack, or stop an allergic reaction in its tracks. But scientists have learned that their story is much more complicated than initially believed—a number of these drugs are in fact targeting a complex composed of one receptor and one associated protein. Now, a ...

Bringing environmental justice to disadvantaged communities

2024-08-27
COLUMBUS, Ohio – Not all communities in the United States face the same risks for environmental problems such as air pollution, noise and wastewater.  But how can federal agencies fairly identify which areas deserve the most help?   A new consensus study report from the National Academies of Sciences, Engineering and Medicine (NASEM) offer recommendations for developing tools that can help answer that question.   “Our job was to create methods to identify disadvantaged communities that most need federal resources to address environmental justice issues,” said Harvey Miller, ...

Wiener studying learning & metacognition for the perception of time

2024-08-27
Wiener Studying Learning & Metacognition For The Perception Of Time Martin Wiener, Associate Professor, Psychology, College of Humanities and Social Sciences (CHSS), received funding to study learning and metacognition for the perception of time.  Via this research, Wiener will conduct a series of studies that will inform metacognition and interval timing. He holds that this work will lead to a new domain of study to further understand how humans learn and adapt to temporal intervals. By understanding how the brain measures and learns intervals of time, we can better understand ...

Dumas receives funding for study of how distinct NMDA receptor signaling domains regulate hippocampal network dynamics

2024-08-27
Dumas Receives Funding For Study Of How Distinct NMDA Receptor Signaling Domains Regulate Hippocampal Network Dynamics Theodore Dumas, Associate Professor, Psychology, College of Humanities and Social Sciences (CHSS), received funding for the project: “Distinct NMDA receptor signaling domains regulate hippocampal network dynamics. Dumas and his collaborators hypothesize that in wildtype mice, NMDA receptors regulate hippocampal network oscillatory activity (slow gamma frequency) in the absence of ion conductance (nonionotropic) and that enhancing GluN2B subunit-type nonionotropic signaling will increase slow gamma power and enhance spatial memory retrieval. The researchers ...

Second genetic sensor for DNA methylation discovered

2024-08-27
DNA methylation is a process in which a methyl group is attached to the cytosine base of the DNA molecule, and a major way that DNA is epigenetically marked. Epigenetic modifications can act as on-off switches to regulate gene expression and help generate diverse cell types without changing the underlying DNA sequence. It is how the body ensures that brain-related genes don’t get turned on in heart cells, for example. For this reason, maintenance of the DNA methylation pattern is important to ensure the correct and consistent function of each cell type. But this is no easy feat: the DNA methylation pattern can change over time, and this is linked to a variety of diseases. One ...

New sensor technology enhances detection of tiny particles

New sensor technology enhances detection of tiny particles
2024-08-27
In recent years, advances in photonics and materials science have led to remarkable developments in sensor technology, pushing the boundaries of what can be detected and measured. Among these innovations, non-Hermitian physics has emerged as a crucial area of research, offering new ways to manipulate light and enhance sensor sensitivity. A recent study published in Advanced Photonics Nexus reports a breakthrough in this field, presenting a new type of sensor that leverages exceptional points (EPs) to achieve unprecedented levels of sensitivity. This study introduces a highly sensitive and reconfigurable sensor based on a single ...

New technology ‘lights up’ bacteria in wounds for better infection prevention

New technology ‘lights up’ bacteria in wounds for better infection prevention
2024-08-27
LOS ANGELES — Over 6.5 million Americans experience chronic wounds — wounds that do not heal after a few months. Almost all such wounds contain bacteria, which, if not detected and removed, can lead to severe infection and resulting complications, including amputation if a limb is involved.  This is especially true for patients with diabetic foot ulcers (open sores), which affects one-third of people with diabetes. Approximately 20% of those who develop a diabetic foot ulcer will require a lower-extremity amputation, according ...

UCLA receives $120 million from Alya and Gary Michelson for new California Institute for Immunology and Immunotherapy

UCLA receives $120 million from Alya and Gary Michelson for new California Institute for Immunology and Immunotherapy
2024-08-27
UCLA has received a $120 million commitment from surgeon, inventor and philanthropist Dr. Gary Michelson and his wife, Alya, to kick-start the California Institute for Immunology and Immunotherapy, an innovative public-private partnership aimed at spurring breakthrough discoveries that prevent and cure diseases and catalyze economic growth and innovation in Los Angeles.  Michelson, a spine surgeon and prolific inventor who holds nearly 1,000 individual patents, is co-founder and chair of the board of the institute, which will be housed at UCLA’s state-of-the-art research park. The gift, distributed via ...

Dunick receives funding for Center For Economic Education

2024-08-27
Dunick Receives Funding For Center For Economic Education Jason Dunick, Associate Chair and Term Associate Professor, Economics, College of Humanities and Social Sciences (CHSS), received $108,692 from Virginia Council on Economic Education for: “Center for Economic Education.” Dunick will use this funding to support the continuation of the services of the Center for Economic Education. The Center supports K-12 teachers who are teaching economics and personal finance in Virginia. This grant represents the renewal of a long-standing relationship with the ...

National Institutes of Health awards $2.4 million grant to cross-disciplinary team of researchers to study psychedelics for methamphetamine addiction

2024-08-27
FOR IMMEDIATE RELEASE Media Contacts: Colleen McDonald Sr. Consultant, Earned Media Kara Reed Director of Development Lisa Babin Executive Director of Communications Medical College of Wisconsin University of California San Diego LSU Health Shreveport  414.801.3146 | cmcdonald@mcw.edu 217.390.6629 | k3hendrickson@ucsd.edu 318.675.8769 | lisa.babin@lsuhs.edu   Milwaukee, Wis., August 27, 2024 – John McCorvy, PhD, Assistant Professor in the Department ...

LAST 30 PRESS RELEASES:

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

[Press-News.org] Atomic resolution of the broad-spectrum antiviral drug cascade to facilitate the design of antiviral drugs